Close
Written By: Jeffrey Atlas, PA-C, Health Content Writer
Medically Reviewed By: Dr. Gopal Grandhige, MD, FACS, Board-Certified Surgeon
Last Reviewed: May 29, 2026
Tesamorelin can reduce certain cholesterol markers. Multiple clinical trials show that tesamorelin at a 2mg daily dose lowers triglycerides, total cholesterol, and the total cholesterol-to-HDL ratio over treatment periods of 12 to 52 weeks. A 2007 study published in the New England Journal of Medicine found that tesamorelin decreased the total cholesterol-to-HDL ratio by 0.31 and dropped triglycerides by 50 mg/dL compared to placebo (p<0.001). A separate randomized trial published in PLOS One showed total cholesterol fell by roughly 11.6 mg/dL in the 2mg group over 12 weeks (p<0.05 vs. placebo).
But there’s a caveat that gets left out of most conversations. Tesamorelin is FDA-approved solely for reducing excess abdominal fat in HIV-infected adults with lipodystrophy. The cholesterol improvements are secondary findings tied to visceral fat reduction, not a primary indication. And longer-term data shows HDL cholesterol may slightly decrease rather than improve. This isn’t a statin. It’s a metabolic tool with real data behind it, but the data tells a more specific story than most wellness sites admit.
This article won’t cover GLP-1 receptor agonists, semaglutide, or statin alternatives. We’re staying focused on what tesamorelin does (and doesn’t do) for your lipid panel, why that matters, and why how you access it changes everything about the outcome.
Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog. It’s a peptide that tells your pituitary gland to produce more growth hormone naturally, rather than injecting growth hormone directly. When administered as a daily subcutaneous injection (usually into the abdomen), it binds to GHRH receptors on the pituitary gland and triggers a natural pulse of growth hormone release. That growth hormone then increases levels of insulin-like growth factor 1 (IGF-1), which sets off a cascade of metabolic effects.
One of those effects is visceral fat reduction. And this is where the cholesterol connection becomes clear. Visceral fat isn’t just a cosmetic issue. It’s an active endocrine organ that secretes inflammatory cytokines, drives insulin resistance, and directly worsens your lipid profile. Reduce it, and the downstream metabolic numbers start moving in the right direction.
The mechanism behind the cholesterol reduction appears to work through two pathways. Growth hormone stimulates hepatic LDL receptor expression, which helps clear LDL particles from your bloodstream. It also increases the activity of acyl coenzyme A cholesterol acyltransferase (ACAT), a rate-limiting enzyme in bile acid production. Both pathways push total and non-HDL cholesterol down.
Actually, that framing isn’t quite right on its own. The lipid improvements from tesamorelin aren’t purely a direct pharmacological cholesterol effect the way statins work. They’re largely a downstream consequence of burning visceral fat, which removes a source of metabolic inflammation. The liver receptor pathway adds to it, but the visceral fat reduction is doing most of the heavy lifting.
The data is more solid than you’d expect for a peptide. Most peptides that show up in social media feeds have zero Phase III trial data behind them. Tesamorelin has multiple randomized, placebo-controlled trials published in major journals. That puts it in a different category entirely.
The NEJM Trial (Falutz et al., 2007): This was the landmark study. Patients receiving tesamorelin saw visceral fat drop by 15.2%, while the placebo group’s visceral fat actually increased by 5%. Triglycerides fell by 50 mg/dL in the tesamorelin group while rising 9 mg/dL in the placebo group. The total cholesterol-to-HDL ratio improved by 0.31. Total cholesterol and HDL both showed significant improvement at the 26-week mark.
The 52-Week Extension (Falutz et al., 2010): Triglyceride reductions sustained at roughly 51 mg/dL over a full year. Visceral fat reduction maintained at approximately 18%. But here’s where the data gets more nuanced. HDL cholesterol showed a minimal but statistically significant decrease in the longer-term treatment arm. I’ve seen this detail get ignored in most blog posts about tesamorelin. It matters because someone reading this might assume tesamorelin will raise their HDL. It probably won’t. It may even nudge it slightly in the wrong direction over 12 months. The triglyceride and total cholesterol improvements are the stronger signal.
The PLOS One Type 2 Diabetes Trial (Clemmons et al., 2017): In 53 patients with type 2 diabetes, the 2mg group saw total cholesterol decrease by 0.3 mmol/L (about 11.6 mg/dL) and non-HDL cholesterol decrease by the same amount over 12 weeks. Both reductions were statistically significant compared to placebo. And importantly, diabetes control didn’t worsen. No patients withdrew due to blood sugar problems.
The 2025 Cardiovascular Analysis (Grinspoon et al.): A combined analysis of 543 patients from two Phase III trials found that tesamorelin reduced 10-year atherosclerotic cardiovascular disease risk by 0.40%. That reduction was driven primarily by decreases in total cholesterol, independent of whether patients were already on lipid-lowering medications. For patients who started with higher baseline cardiovascular risk, the benefit was even more pronounced (p=0.038).
One more thing worth knowing: effects reversed when treatment stopped. Visceral fat came back. Some lipid benefits partially persisted short-term, but this isn’t a one-and-done treatment. That’s not a flaw in the drug. It’s how biology works. You don’t keep the benefits of exercise after you stop exercising either.
It does, and triglycerides may actually be where the strongest and most consistent signal sits. The NEJM trial showed a 50 mg/dL triglyceride drop. For context, the American Heart Association considers anything above 150 mg/dL elevated. A 50-point reduction can shift someone from a concerning range into a more favorable one.
A study from Theratechnologies (the company behind Egrifta) analyzed 400 participants and found that among treatment responders, resolution of elevated triglycerides occurred in 17.5% compared to just 8% of non-responders (p=0.026). That gap was driven by the degree of visceral fat reduction. The more fat you lose in the midsection, the better the triglyceride numbers move.
The tesamorelin and sermorelin comparison is worth understanding here. Sermorelin also stimulates growth hormone, but the lipid data behind tesamorelin is significantly stronger. If your primary concern is metabolic markers like triglycerides and cholesterol ratios, tesamorelin has the clinical evidence. Sermorelin is better suited for general body composition and recovery goals.
A 2021 study published in PMC found that improvements in adipose tissue quality (not just quantity) from tesamorelin correlated with decreases in both total cholesterol and triglyceride concentrations. This means tesamorelin isn’t just shrinking fat cells. It appears to change how your fat tissue functions at the metabolic level.
I’ll be direct about limitations though. There’s no strong evidence of broad LDL reduction comparable to statins. And there are no dedicated large trials from 2024 through 2026 studying tesamorelin solely for primary hypercholesterolemia. If your cholesterol is genetically driven and unrelated to body composition, tesamorelin probably isn’t the answer. It works best in people whose lipid issues are connected to visceral fat accumulation, metabolic syndrome, or insulin resistance.
Social media has created a DIY methodology around peptides, and I’ll say it plainly: it’s a problem. Peptides are trending, but they aren’t just for a moment. They’re one tool in the clinical toolbox. The point is not to hop on a trend. It’s to get results.
We all want more energy, better recovery, improved body composition, and better quality of life. And peptides can help with those things. Peptides aren’t good or bad on their own. The question is whether they’re being used intentionally, appropriately, and with a real care plan. If they’re not, they’re unpredictable, because they act throughout the body.
Here’s the analogy that puts this in perspective. Insulin is a peptide. Nobody calls insulin a trend. Insulin is a powerful molecule created by the body that can cause significant harm if used incorrectly, but it’s also life-saving when used correctly. The same principle applies to tesamorelin. A peptide is not a plan. A vial is not a strategy. Self-experimentation is not the same thing as clinician-guided care.
Peptide culture is increasingly shaped by influencer sales funnels, gray-market sourcing, and self-experimentation. That’s not a care model. That’s a trend cycle. And it doesn’t make peptides a trend. Peptides are simply being used as a trend to make quick money.
The research-grade tesamorelin people order online is labeled “not for human use” for a reason. These products come from unregulated sources with no guarantees on purity, sterility, or accurate dosing. At Formation, we only use human-grade medications from licensed compounding pharmacies. The difference shows up in safety and in results. If you’re injecting a peptide to improve your metabolic profile, the last thing you want is a product that wasn’t manufactured for human use.
There’s a question people don’t ask often enough: what happens if the peptide doesn’t work? Or what happens if it works but creates a different problem? Most people ordering peptides online have no monitoring plan. No baseline labs. No one checks IGF-1 levels (which need to stay within range) or watches glucose (which tesamorelin can affect in certain populations).
We’ve seen this play out with patients who come in after running their own protocols for months. Some had no idea their IGF-1 was elevated beyond the physiological range. Others didn’t realize their fasting glucose had crept up. These aren’t rare complications. They’re predictable outcomes when nobody’s watching the numbers.
The clinical trials that produced the cholesterol data referenced in this article all had strict monitoring protocols. Baseline labs, regular follow-ups, dose adjustments when needed. That context matters. You can’t take the results from a tightly controlled clinical trial and assume you’ll get the same outcome from a research-grade vial and a Reddit dosing guide.
At Formation, a regenerative medicine clinic in Tampa, we don’t hand someone a vial and wish them luck. We answer a series of questions first. Is this person actually a fit? What’s the goal? What should be ruled out first? What should be monitored over time? What if it’s not worth continuing?
We build a strategy around the individual, the goal, the full clinical picture, and whether the treatment is actually working. That’s the difference between a protocol and a plan.
Jeff Atlas, PA-C, handles peptide injections at Formation. Jeff’s background is in orthopedics, and he brings hands-on experience in musculoskeletal health, regenerative techniques, and injection precision to every session. When patients ask who will actually be administering their injections, the answer is a clinician with real procedural experience.
Formation also has a concierge dietitian who works directly with peptide therapy patients to optimize their nutrition during treatment. If you’re trying to improve your cholesterol with tesamorelin but you’re eating in a way that actively works against your lipid panel, the peptide can only do so much. Nutrition isn’t a side note in peptide therapy. It’s a multiplier. The dietitian builds a personalized nutritional plan designed to support the specific metabolic processes tesamorelin activates in your body.
Formation holds both SSRP and ISSCA certifications, which are organizations that certify peptide, exosome, and stem cell protocols. That means the clinic meets third-party standards for how these therapies are sourced, stored, and administered.
Dr. Gopal Grandhige, a board-certified surgeon who specializes in aesthetic surgery, founded Formation to bring inner and outer wellness together under one roof. Peptide therapy sits under the regenerative medicine arm of the clinic. It’s a separate track from the surgical side, but it shares the same standard: everything is clinician-guided, monitored, and adjusted based on how you’re actually responding.
If you’re interested in whether tesamorelin could support your metabolic health, the first step is a consultation. Not a sales pitch. A clinical evaluation to figure out if you’re a good candidate and what a real plan looks like for your specific situation. Call (813) 922-2920 to schedule, or visit formation.
Tesamorelin can improve certain cholesterol markers, but it’s not a blanket cholesterol drug. The strongest clinical signal sits with triglycerides and the total cholesterol-to-HDL ratio, both driven by visceral fat reduction rather than a direct pharmacological effect on lipids. If your cholesterol problems are tied to excess belly fat, metabolic syndrome, or insulin resistance, the data gives you a real reason to have the conversation with a clinician.
What it won’t do is replace statins for genetically driven hypercholesterolemia or reliably raise your HDL over the long term. And it definitely won’t work the way the clinical trials showed if you’re sourcing research-grade vials online and running your own protocol without monitoring. The outcomes in those studies came from pharmaceutical-grade tesamorelin, regular lab work, and medical oversight. Remove any of those pieces and you’re guessing.
If you’re in Tampa and want to know whether tesamorelin fits your metabolic picture, Formation offers a clinical evaluation that starts with labs, not a sales pitch. Jeff Atlas, PA-C, administers all peptide injections, and our concierge dietitian builds a nutrition plan around your protocol. Call (813) 922-2920 or visit Formation to get started.
No. Tesamorelin reduces cholesterol primarily by burning visceral fat, which removes a major source of metabolic inflammation, while statins block cholesterol production directly in the liver. The strongest improvements show up in triglycerides and total cholesterol-to-HDL ratios rather than broad LDL reduction.
Most clinical trials show measurable lipid changes between 12 and 26 weeks of daily use at the 2mg dose. Meaningful shifts in your lipid panel typically require at least three months of consistent treatment with regular lab monitoring.
Visceral fat tends to return after discontinuation, and most lipid benefits decline over time without continued treatment. Some triglyceride improvements may partially persist short-term, but the data is clear that this isn't a one-and-done fix.
Probably not. Research-grade peptides sold online are labeled "not for human use," aren't regulated for purity or dosing accuracy, and carry none of the clinical monitoring that produced the trial results referenced in this article.
A 12-week randomized trial found no worsening of fasting glucose, HbA1c, or diabetes control at the 2mg dose. Cholesterol markers improved in that group without negatively affecting blood sugar management.
The last one got 11/10.
Some of the biggest factors affecting liposuction results have nothing to do with what happens in the operating room.
Dr. Gopal rates 13 factors that can influence the final result, from working out before surgery and maintaining a stable weight to compression garments, skin elasticity, and lymphatic massage.
A few of his ratings might surprise you.
For example, he rates skin elasticity a 10/10 because even after the fat is removed, the skin still needs to contract and settle over the new contour.
And lymphatic massage? He gives it an 11/10 because of the role it plays in his recovery protocol, helping manage swelling and supporting how the skin settles over the newly sculpted areas.
The takeaway: great liposuction results depend on more than the surgery itself.
Patient preparation, anatomy, recovery, and long-term weight maintenance all play a role.
Considering liposuction or high-definition liposuction in Tampa?
Schedule a consultation with Dr. Gopal Grandhige at Formation Tampa. Link in bio.
#Liposuction #HDLiposuction #LiposuctionRecovery #LipoAftercare #tampa
Six to seven hours.
That’s how long an HD liposuction procedure can take with Dr. Gopal’s approach.
He’s not simply removing fat. He’s evaluating every square inch, considering the underlying anatomy, and shaping how each contour transitions into the next.
It’s detailed, physically demanding work.
So when Dr. Gopal says, “Someone’s gotta sweat for the fat to come off,” he means it.
Considering HD liposuction in Tampa? Schedule a consultation (link in bio).
#HDLiposuction #HighDefinitionLiposuction
Will neck lipo give you the jawline you want?
It depends…
Someone can have fullness under the chin and assume the answer is neck liposuction. But what looks like “fat” from the outside can actually come from several different structures.
Some fat sits directly beneath the skin and can respond very well to liposuction.
But fullness can also come from deeper fat beneath the platysma, the salivary glands under the jaw, muscles under the chin, or even the natural projection of the chin and jaw itself.
That distinction can completely change what neck liposuction can realistically accomplish.
This is why evaluating the anatomy matters before deciding on a procedure.
For the right anatomy, neck liposuction can create a significant change in the neck and jawline.
But when deeper structures are contributing to the fullness, liposuction alone may not create the contour someone is expecting.
A good neck lipo consultation should figure that out first.
Schedule a consultation with **Dr. Gopal Grandhige at Formation Tampa.** Link in bio.
#NeckLipo #NeckLiposuction #DoubleChin #JawlineContouring #NeckContouring
Want more definition than workouts gave you?
Traditional liposuction focuses primarily on removing fat. HD liposuction goes further. It requires understanding the underlying muscle anatomy, where to remove fat, where to preserve it, and how each contour works together to create natural-looking definition.
That’s the art of it. The goal isn’t to give every patient the same abs or the same body. It’s to work with the anatomy that’s already there and determine how much definition will look right for that individual.
Dr. Gopal Grandhige specializes in high-definition liposuction and advanced body contouring, using nearly two decades of surgical experience to create results that look sculpted, athletic, and intentional.
Considering HD liposuction in Tampa?
Schedule a consultation with Dr. Gopal at Formation Tampa. Link in bio.
#HDLiposuction #HighDefinitionLiposuction #Liposuction #BodyContouring #Tampa
Defined abs with HD liposuction.
Unlike traditional liposuction, where the primary goal is removing excess fat, HD liposuction is about strategically removing fat to reveal and enhance the underlying muscle structure.
Those markings you see before surgery help Dr. Gopal map out the patient’s anatomy and plan where to remove fat and where to preserve it to create more visible definition.
The second clip was taken immediately after surgery, so this is not the final result. Swelling and bruising will change significantly as the body heals and the final contour develops over the months that follow.
Considering high-definition liposuction? Schedule a consultation with Dr. Gopal Grandhige at Formation Tampa. Link in bio.
#HDLiposuction #HighDefinitionLiposuction #Liposuction #BodyContouring #MaleLiposuction
Skin quality changes everything.
Neck liposuction can create a more defined jawline and neck contour by removing unwanted fat, but the result also depends heavily on skin quality and elasticity.
When skin has good elasticity, neck lipo alone may be enough for the skin to contract around the new contour. With some skin laxity, Dr. Gopal may combine liposuction with a skin-tightening treatment such as Renuvion or FaceTite. With significant laxity, a neck lift may be the more appropriate option.
That’s why evaluating the skin is an important part of determining the right approach before neck liposuction.
Considering neck liposuction in Tampa? Schedule a consultation with Dr. Gopal Grandhige at Formation Tampa.
#NeckLiposuction #NeckLipo #JawlineContouring #Tampa
Liposuction can change more than the body.
I’ve watched patients become more confident, make changes in their careers, show up differently in their relationships, and start making different choices for themselves.
That’s when I know I’ve done my job well.
Because high-definition liposuction isn’t only about creating a leaner, more defined physique. Sometimes the physical transformation becomes the catalyst for changes that reach far beyond the operating room.
Dr. Gopal Grandhige
Considering HD liposuction in Tampa? Schedule a consultation with Dr. Gopal Grandhige at Formation Tampa.
#BodyContouring #HDLiposuction #tampa #Liposuction
Male liposuction requires a different approach.
The contours that create a more feminine shape aren’t necessarily the same ones that create a strong, athletic male physique.
With male high-definition liposuction, Dr. Gopal considers how the chest, abdomen, waist, ribs and back work together—and how the underlying muscle anatomy should guide where definition and shadow are created.
That’s also why the chest matters. A highly defined abdomen and back paired with a rounder, less-defined chest can make the overall result feel out of proportion.
The goal is a cohesive, athletic contour that works with the patient’s natural anatomy.
Considering male HD liposuction? Schedule a consultation with Dr. Gopal Grandhige at Formation Tampa.
Choosing a liposuction surgeon isn’t just about looking at before-and-afters.
Liposuction isn’t simply about removing fat. Decisions around how much to remove, which areas to treat, skin quality, post-op care and recovery can all influence the approach to your result.
How a surgeon answers these questions can tell you a lot about how they think, plan and care for their patients.
Save these 6 questions for your next consultation.
Considering liposuction? DM us or schedule a consultation with Dr. Gopal Grandhige at Formation Tampa.
#tampa #hdliposuction #liposuction #bodycountouring
6 months post high-definition liposuction with moderate definition.
The goal wasn’t just less fat. It was a leaner, more athletic contour with visible definition through the abdomen and torso, without pushing the result to the highest level of definition.
High-definition liposuction strategically sculpts around the underlying anatomy and can be customized based on a patient’s anatomy, muscle structure, and the degree of definition they want to achieve.
For this patient, moderate definition created the balance Dr. Gopal was looking for.
Results vary by patient and depend on individual anatomy, skin quality, and treatment plan.
Considering HD liposuction? Schedule a consultation with Dr. Gopal Grandhige at Formation Tampa. Link in bio.
#HDLiposuction #Liposuction #BodyContouring #MaleLiposuction #tampa
References:
Falutz, J., Allas, S., Blot, K., Potvin, D., Kotler, D., Somero, M., Berger, D., Brown, S., Richmond, G., Fessel, J., Turner, R., & Grinspoon, S. (2007). Metabolic effects of a growth hormone-releasing factor in patients with HIV. New England Journal of Medicine, 357(23), 2359–2370. https://www.nejm.org/doi/full/10.1056/NEJMoa072375
Falutz, J., Mamputu, J. C., Potvin, D., Moyle, G., Soulban, G., Loughrey, H., Marsolais, C., Turner, R., & Grinspoon, S. (2010). Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: A pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data. Journal of Clinical Endocrinology & Metabolism, 95(9), 4291–4304. https://pubmed.ncbi.nlm.nih.gov/20554713/
National Institute of Diabetes and Digestive and Kidney Diseases. (2018). Tesamorelin. In LiverTox: Clinical and research information on drug-induced liver injury. National Institutes of Health. https://www.ncbi.nlm.nih.gov/books/NBK548730/
Russo, S. C., Ockene, M. W., Arpante, A. K., Johnson, J. E., Lee, H., Toribio, M., Stanley, T. L., Hadigan, C. M., Grinspoon, S. K., Erlandson, K. M., & Fourman, L. T. (2024). Efficacy and safety of tesamorelin in people with HIV on integrase inhibitors. AIDS, 38(12), 1758–1764. https://pubmed.ncbi.nlm.nih.gov/38905488/
Stanley, T. L., Feldpausch, M. N., Oh, J., Branch, K. L., Lee, H., Torriani, M., & Grinspoon, S. K. (2014). Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: A randomized clinical trial. JAMA, 312(4), 380–389. https://pubmed.ncbi.nlm.nih.gov/25038357/
